• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Stopping β-Blockers After Myocardial Infarction: Not So Fast!

作者信息

Ko Dennis T, Jackevicius Cynthia A

机构信息

Schulich Heart Centre, Sunnybrook Health Sciences Centre (D.T.K.) and Institute of Health Policy, Management and Evaluation (D.T.K., C.A.J.), University of Toronto, Canada. Institute for Clinical Evaluative Sciences, Toronto, Canada (D.T.K., C.A.J.). Department of Pharmacy Practice and Administration, College of Pharmacy, Western University of Health Sciences, Pomona, CA (C.A.J.). Pharmacy Department, Veterans Affairs Greater Los Angeles Healthcare System (C.A.J.). Pharmacy Department, University Health Network, Toronto, Canada (C.A.J.).

出版信息

Circ Cardiovasc Qual Outcomes. 2018 Apr;11(4):e004678. doi: 10.1161/CIRCOUTCOMES.118.004678.

DOI:10.1161/CIRCOUTCOMES.118.004678
PMID:29654002
Abstract
摘要

相似文献

1
Stopping β-Blockers After Myocardial Infarction: Not So Fast!心肌梗死后停用β受体阻滞剂：别急！
Circ Cardiovasc Qual Outcomes. 2018 Apr;11(4):e004678. doi: 10.1161/CIRCOUTCOMES.118.004678.
2
Are beta-blockers effective in patients who develop heart failure soon after myocardial infarction? A meta-regression analysis of randomised trials.β受体阻滞剂对心肌梗死后不久发生心力衰竭的患者是否有效？一项随机试验的Meta回归分析。
Eur J Heart Fail. 2000 Sep;2(3):333-40. doi: 10.1016/s1388-9842(00)00100-8.
3
β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study.β受体阻滞剂与无心力衰竭心肌梗死患者的死亡率：多中心前瞻性队列研究
BMJ. 2016 Oct 17;355:i5602. doi: 10.1136/bmj.i5602.
4
β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study.β受体阻滞剂与无心力衰竭心肌梗死患者的死亡率：多中心前瞻性队列研究
BMJ. 2016 Sep 20;354:i4801. doi: 10.1136/bmj.i4801.
5
Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials.β受体阻滞剂用于心肌梗死的临床结局：随机试验的荟萃分析
Am J Med. 2014 Oct;127(10):939-53. doi: 10.1016/j.amjmed.2014.05.032. Epub 2014 Jun 11.
6
Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative.β受体阻滞剂治疗与慢性阻塞性肺疾病和心力衰竭或左心室功能障碍患者心肌梗死后死亡率的关系：来自高危心肌梗死数据库倡议的倾向匹配队列分析。
Eur J Heart Fail. 2017 Feb;19(2):271-279. doi: 10.1002/ejhf.647. Epub 2016 Oct 24.
7
Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.β 受体阻滞剂治疗与非心脏手术缺血性心脏病患者不良心血管事件和死亡风险的关联：一项丹麦全国队列研究。
JAMA Intern Med. 2014 Mar;174(3):336-44. doi: 10.1001/jamainternmed.2013.11349.
8
[Adherence to medication after myocardial infarction and its impact on outcome: a registry-based analysis from the Hungarian Myocardial Infarction Registry].[心肌梗死后药物治疗依从性及其对预后的影响：基于匈牙利心肌梗死登记处的分析]
Orv Hetil. 2017 Jul;158(27):1051-1057. doi: 10.1556/650.2017.30795.
9
Heart failure in acute myocardial infarction: a comparison between patients with or without heart failure criteria from the FAST-MI registry.急性心肌梗死中的心力衰竭：来自FAST-MI注册研究中符合或不符合心力衰竭标准患者的比较。
Rev Esp Cardiol (Engl Ed). 2012 Apr;65(4):326-33. doi: 10.1016/j.recesp.2011.10.027. Epub 2012 Feb 20.
10
Adherence to ACC/AHA performance measures for myocardial infarction in six Middle-Eastern countries: association with in-hospital mortality and clinical characteristics.在六个中东国家中，对 ACC/AHA 心肌梗死绩效指标的遵守情况与住院死亡率和临床特征的关系。
Int J Cardiol. 2013 Aug 20;167(4):1406-11. doi: 10.1016/j.ijcard.2012.04.066. Epub 2012 May 10.

引用本文的文献

1
The Hypertension Paradox: Survival Benefit After ST-Elevation Myocardial Infarction in Patients With History of Hypertension. A Prospective Cohort- and Risk-Analysis.高血压悖论：高血压病史患者ST段抬高型心肌梗死后的生存获益。一项前瞻性队列研究和风险分析。
Front Cardiovasc Med. 2022 Feb 24;9:785657. doi: 10.3389/fcvm.2022.785657. eCollection 2022.
2
The duration of beta-blocker therapy and outcomes in patients without heart failure or left ventricular systolic dysfunction after acute myocardial infarction: A multicenter prospective cohort study.急性心肌梗死后无心力衰竭或左心室收缩功能障碍患者的β受体阻滞剂治疗持续时间和结局：一项多中心前瞻性队列研究。
Clin Cardiol. 2022 May;45(5):509-518. doi: 10.1002/clc.23807. Epub 2022 Mar 4.
3
Cardiolipin remodeling by ALCAT1 links hypoxia to coronary artery disease by promoting mitochondrial dysfunction.
ALCAT1 通过重塑心磷脂将低氧与冠状动脉疾病联系起来，通过促进线粒体功能障碍。
Mol Ther. 2021 Dec 1;29(12):3498-3511. doi: 10.1016/j.ymthe.2021.06.007. Epub 2021 Jun 8.
4
β-blockers after myocardial infarction and 1-year clinical outcome - a retrospective study.心肌梗死后使用β受体阻滞剂和 1 年临床结局 - 一项回顾性研究。
BMC Cardiovasc Disord. 2020 Apr 9;20(1):165. doi: 10.1186/s12872-020-01441-0.